Limited Evidence for the Health Effects and Safety of Intermittent Fasting Among Patients With Type 2 Diabetes

JAMA. 2020 Jul 28;324(4):341-342. doi: 10.1001/jama.2020.3908.

Authors

Benjamin D Horne^{1

2}, Martin M Grajower³, Jeffrey L Anderson^{1

4}

Affiliations

¹ Intermountain Medical Center Heart Institute, Salt Lake City, Utah.
² Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California.
³ Division of Endocrinology, Albert Einstein College of Medicine, Bronx, New York.
⁴ Cardiology Division, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.

PMID: 32614382
DOI: 10.1001/jama.2020.3908

No abstract available

MeSH terms

Caloric Restriction / methods*
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / diet therapy*
Diabetes Mellitus, Type 2 / drug therapy
Energy Intake / physiology
Fasting / adverse effects
Fasting / physiology*
Hemoglobin A / metabolism
Humans
Hypoglycemia / chemically induced
Hypoglycemic Agents / adverse effects
Hypoglycemic Agents / therapeutic use
Insulin Resistance / physiology
Safety
Time Factors
Weight Loss

Substances

Hypoglycemic Agents
Hemoglobin A